BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 168779)

  • 1. Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells.
    Bigazzi PE; Yoshida T; Ward PA; Cohen S
    Am J Pathol; 1975 Jul; 80(1):69-78. PubMed ID: 168779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF-like activity in non-stimulated and virus infected cell cultures.
    Brown EW; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(5):419-24. PubMed ID: 213010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.
    Yoshida T; Kuratsuji T; Takada A; Takada Y; Minowada J; Cohen S
    J Immunol; 1976 Aug; 117(2):548-54. PubMed ID: 781133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production.
    Sonozaki H; Papermaster V; Yoshida T; Cohen S
    J Immunol; 1975 Dec; 115(6):1657-61. PubMed ID: 1102607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines.
    Poste G
    Cancer Res; 1975 Sep; 35(9):2558-66. PubMed ID: 167963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that a target-derived soluble factor is necessary for the selective lysis of SV40-transformed fibroblasts by activated mouse macrophages.
    Laster SM; Gooding LR
    J Immunol; 1990 Feb; 144(4):1438-43. PubMed ID: 2154519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.
    Ward PA; Dvorak HF; Cohen S; Yoshida T; Data R; Selvaggio SS
    J Immunol; 1975 May; 114(5):1523-31. PubMed ID: 1091704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic response of SV40 virus transformed fibroblasts to conditioned medium: dependence on time and cell number.
    Allavena G; Albini A; Parodi S
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2369-75. PubMed ID: 6099133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
    Thurman GB; Braude IA; Gray PW; Oldham RK; Stevenson HC
    J Immunol; 1985 Jan; 134(1):305-9. PubMed ID: 3917277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
    Wahl SM; Altman LC; Rosenstreich DL
    J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of macrophage migration inhibition factors by virus-infected cell cultures.
    Flanagan TD; Yoshida T; Cohen S
    Infect Immun; 1973 Aug; 8(2):145-50. PubMed ID: 4199152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-induced changes in macrophage migration may explain differences in lytic sensitivity among simian virus 40-transformed fibroblasts.
    Laster SM; Wood JG; Gooding LR
    J Immunol; 1988 Jul; 141(1):221-7. PubMed ID: 2837509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to guinea pig lymphokines. VII. Reactivity with products of lymphoid and nonlymphoid cells.
    Sorg C; Geczy CL
    J Immunol; 1978 Sep; 121(3):1199-205. PubMed ID: 99476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochemical and molecular properties of simian virus 40 transformed Kaposi's sarcoma-derived cells: evidence for the secretion of a member of the fibroblast growth factor family.
    Werner S; Hofschneider PH; Stürzl M; Dick I; Roth WK
    J Cell Physiol; 1989 Dec; 141(3):490-502. PubMed ID: 2556409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.